Are you or a loved one suffering from NASH?
The cause of non-alcoholic fatty liver disease (NASH or NALFD) is unknown. Risk factor include obesity, gastric bypass surgery, high cholesterol and type 2 diabetes. If you or a loved one have been diagnosed with NASH, this clinical trial may be a right fit.
Local doctors are conducting a clinical research study to test the safety and effectiveness of an investigational drug for treatment of liver fibrosis in adults with NASH.
Qualified participants must:
Be 18-75 years old
Have diagnosis of NASH
Have evidence of stage 3 liver fibrosis
Be willing and able to sign written informed consent
Qualified participants may receive all study-related care and study drug at no cost. Compensation may be available for participation as well.
To learn more about this study and how you can participate, click on the button below.
By filling out this form, you agree to your information potentially being added to a patient database, along with a study coordinator reaching out to you.